SCHEMBL28465474

SCHEMBL28465474

Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(CCC(C)OC3CCCCO3)c3ccccc23)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 12/20 0.62
TNF P01375 3/20 0.54
MAPK12 P53778 10/20 0.54
HCK P08631 7/20 0.54
MAPK13 O15264 2/20 0.54
MAPK11 Q15759 2/20 0.54
DDR2 Q16832 2/20 0.54
ABL1 P00519 2/20 0.54
RAF1 P04049 2/20 0.54
LYN P07948 2/20 0.54
SRC P12931 2/20 0.54
MAPK9 P45984 2/20 0.54
CIT O14578 1/20 0.54
MUSK O15146 1/20 0.54
MAP3K7 O43318 1/20 0.54
RIPK2 O43353 1/20 0.54
STK10 O94804 1/20 0.54
MAP4K4 O95819 1/20 0.54
CHEK2 O96017 1/20 0.54
EGFR P00533 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL299835 0.87 MAPK14 (0.68) MAPK14TNFMAPK12HCKMAPK13
SCHEMBL370624 0.87 MAPK14 (0.62) MAPK14TNFMAPK12HCKMAPK13
SCHEMBL296076 0.84 MAPK14 (0.53) MAPK14TNFMAPK12HCKMAPK13
SCHEMBL28465490 0.81 MAPK14 (0.76) MAPK14TNFMAPK12HCKMAPK13
SCHEMBL20876951 0.80 MAPK14 (0.55) MAPK14TNFMAPK12HCKMAPK13
SCHEMBL297067 0.80 MAPK14 (0.55) MAPK14TNFMAPK12HCKMAPK13
SCHEMBL28458630 0.80 MAPK14 (0.78) MAPK14TNFMAPK12HCKMAPK13
SCHEMBL28468353 0.78 MAPK14 (0.78) MAPK14TNFMAPK12HCKMAPK13
SCHEMBL28458603 0.77 MAPK14 (0.69) MAPK14TNFMAPK12HCKMAPK13
SCHEMBL294394 0.77 MAPK14 (1.00) MAPK14TNFMAPK12HCKMAPK13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114748622-B P38 kinase inhibitors reduce DUX4 and downstream gene expression and treat FSHD 弗尔康医疗公司 2024-09-24 CN disclosed
CN-114732910-B P38 kinase inhibitors reduce DUX4 and downstream gene expression and treat FSHD 弗尔康医疗公司 2024-08-23 CN disclosed
CN-114748622-A P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD 弗尔康医疗公司 2022-07-15 CN disclosed
CN-114732910-A P38 kinase inhibitor reduces DUX4 and downstream gene expression for treatment of FSHD 弗尔康医疗公司 2022-07-12 CN disclosed
CN-111601593-B P38 kinase inhibitor reduces DUX4 and downstream gene expression for treatment of FSHD 弗尔康医疗公司 2022-04-15 CN disclosed
CN-111601593-A P38 kinase inhibitor reduces DUX4 and downstream gene expression for treatment of FSHD 弗尔康医疗公司 2020-08-28 CN disclosed